Midgut neuroendocrine tumour presenting as orbital metastases

References

• Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97(4):934–959. doi: 10.1002/cncr.11105
   PubMed Web of Science ®Google Scholar
• Couch DA, O’Halloran HS, Hainsworth KM, et al. Carcinoid metastasis to extraocular muscles: case reports and review of the literature. Orbit. 2003;19(4):263–269. doi: 10.1076/orbi.19.4.263.2656
   Google Scholar
• Klimstra DS, Modlin IR, Coppola D, et al. The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems. Pancreas. 2010;39(6):707–712. doi: 10.1097/MPA.0b013e3181ec124e
   PubMed Web of Science ®Google Scholar
• Kim JY, Hong SM. Recent updates on neuroendocrine tumors from the gastrointestinal and pancreatobiliary tracts. Arch Pathol Lab Med. 2016;140(5):437–448. doi: 10.5858/arpa.2015-0314-RA
   PubMed Web of Science ®Google Scholar
• Khaw P, Ball D, Duchesne G. Carcinoid tumour of the orbital muscles: A rare occurrence. Australas Radiol. 2001;45(2):179–181. doi: 10.1046/j.1440-1673.2001.00899.x
   PubMedGoogle Scholar
• Shaygannejad V, Ghasemi M, Rajaee Z. Myasthenia gravis as a presenting feature in a patient with lung cancer: a case report. J Res Med Sci. 2011;16(2):229–232.
   PubMed Web of Science ®Google Scholar
• Hermans MAW, Stelten BML, Haak HR, et al. Two patients with a neuroendocrine tumour of the small intestine and paraneoplastic myasthenia gravis. Endocrinol Diabetes Metab Case Reports. 2014;2014(May):140013. doi:10.1530/EDM-14-0013.
   Google Scholar
• Pusceddu S, Milione M, Ortolani S, et al. Orbital lesions, an exceedingly rare site of neuroendocrine tumor metastasis. J Cancer Metastasis Treat. 2016;2(8):341. doi: 10.20517/2394-4722.2016.41
   Google Scholar
• Mehta P, Malik S, Adesanya O, et al. Orbital carcinoid metastasis: diverse presentations and value of indium-octreotide imaging. Orbit. 2012;31(6):379–382. doi: 10.3109/01676830.2012.711890
   PubMedGoogle Scholar
• Fan JT, Buettner H, Bartley GB, et al. Clinical features and treatment of seven patients with carcinoid tumor metastatic to the eye and orbit. Am J Ophthalmol. 1995;119(2):211–218. doi: 10.1016/S0002-9394(14)73875-9
   PubMed Web of Science ®Google Scholar
• Yang M, Loh A, Seah LL, et al. Neuroendocrine tumors of the orbit - clinicopathological findings in 3 more cases of this rare entity and review of the literature. Orbit. 2011;30(3):145–149. doi: 10.3109/01676830.2011.569629
   PubMedGoogle Scholar
• Turaka K, Mashayekhi A, Shields C, et al. A case series of neuroendocrine (carcinoid) tumor metastasis to the orbit. Oman J Ophthalmol. 2011;4:125–128. doi: 10.4103/0974-620X.91268
   PubMedGoogle Scholar
• Das S, Pineda G, Goff L, et al. The eye of the beholder: orbital metastases from midgut neuroendocrine tumors, a two institution experience. Cancer Imaging. 2018;18(1):1–7. doi: 10.1186/s40644-018-0181-5
   PubMedGoogle Scholar
• Horton KM, Kamel I, Hofmann L, et al. Carcinoid tumors of the small bowel: a multitechnique imaging approach. Am J Roentgenol. 2004;182(3):559–567. doi: 10.2214/ajr.182.3.1820559
   PubMed Web of Science ®Google Scholar
• Ganeshan D, Bhosale P, Yang T, et al. Imaging features of carcinoid tumors of the gastrointestinal tract. Am J Roentgenol. 2013;201(4):773–786. doi: 10.2214/AJR.12.9758
   PubMed Web of Science ®Google Scholar
• Capurso G, Rinzivillo M, Bettini R, et al. Systematic review of resection of primary midgut carcinoid tumour in patients with unresectable liver metastases. Br J Surg. 2012;99(11):1480–1486. doi: 10.1002/bjs.8842
   PubMed Web of Science ®Google Scholar
• Dasari A, Shen C, Halperin D, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3(10):1335–1342. doi: 10.1001/jamaoncol.2017.0589
   PubMed Web of Science ®Google Scholar
• Mehta JS, Abou-Rayyah Y, Rose GE. Orbital carcinoid metastases. Ophthalmology. 2006;113(3):466–472. doi: 10.1016/j.ophtha.2005.10.051
   PubMed Web of Science ®Google Scholar
• Burke AP, Thomas RM, Elsayed AM, et al. Carcinoids of the jejunum and ileum. Cancer. 1997;79(6):1086–1093. doi: 10.1002/(SICI)1097-0142(19970315)79:6<1086::AID-CNCR5>3.0.CO;2-E
   PubMed Web of Science ®Google Scholar
• Bhattacharyya S, Toumpanakis C, Burke M, et al. Features of carcinoid heart disease identified by 2-and 3-dimensional echocardiography and cardiac MRI. Circ Cardiovasc Imaging. 2010;3(1):103–111. doi: 10.1161/CIRCIMAGING.109.886846
   PubMed Web of Science ®Google Scholar
• Veenendaal LM, Borel Rinkes IHM, Lips CJM, et al. Liver metastases of neuroendocrine tumours; early reduction of tumour load to improve life expectancy. World J Surg Oncol. 2006;4:1–6. doi: 10.1186/1477-7819-4-35
   PubMedGoogle Scholar
• Hendrix TR, Atkinson M, Clifton JA, et al. The effect of 5-hydroxytryptamine on intestinal motor function in man. Am J Med. 1957;23(6):886–893. doi: 10.1016/0002-9343(57)90298-X
   PubMed Web of Science ®Google Scholar
• Modlin IM, Pavel M, Kidd M, et al. Review article: somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours. Aliment Pharmacol Ther. 2010;31(2):169–188.
   PubMed Web of Science ®Google Scholar